Ligand Pharmaceuticals | LGND - Stock


Ligand Pharmaceuticals reported $10.26M in Stock for its fiscal quarter ending in June of 2026.





Stock Change Date
Amgen USD 6.22B 34M Jun/2026
Anika Therapeutics USD 28.56M 5.73M Jun/2026
Arrowhead Research USD -173.08M 173.08M Dec/2024
Baxter International USD 2.26B 57M Jun/2026
Bristol-Myers Squibb USD 2.74B 19M Jun/2026
Eli Lilly USD 16.79B 2.26B Jun/2026
Enviri Corporation USD 173.28M 7.27M Mar/2026
Gilead Sciences USD 1.91B 140M Mar/2026
GlaxoSmithKline GBP 6.16B 233M Mar/2026
Glaxosmithkline GBP 6.16B 39M Mar/2026
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Insmed USD 142.38M 9.48M Jun/2026
Intrexon USD 287K 68K Dec/2022
Ionis Pharmaceuticals USD 50.83M 45.28M Jun/2026
Karyopharm Therapeutics USD 4.04M 72K Dec/2025
Ligand Pharmaceuticals USD 10.26M 3M Jun/2026
MacroGenics USD 9.5M 1.59M Mar/2026
Merck USD 6.21B 272M Jun/2026
Pacira USD 134.57M 15.8M Jun/2026
Pfizer USD 9.94B 722M Jun/2026
Rigel Pharmaceuticals USD 13.3M 2.88M Sep/2025
Veracyte USD 22.66M 1.24M Jun/2026